|
KIF1C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.790140E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.878490E-02 |
| Normal-vs-Stage2 |
9.797200E-01 |
| Normal-vs-Stage3 |
1.853790E-02 |
| Normal-vs-Stage4 |
3.317900E-03 |
| Stage1-vs-Stage2 |
3.169900E-02 |
| Stage1-vs-Stage3 |
8.420800E-01 |
| Stage1-vs-Stage4 |
2.554200E-01 |
| Stage2-vs-Stage3 |
3.559900E-02 |
| Stage2-vs-Stage4 |
1.041970E-02 |
| Stage3-vs-Stage4 |
3.457200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.174200E-02 |
| Normal-vs-AfricanAmerican |
1.896760E-01 |
| Normal-vs-Asian |
4.241700E-02 |
| Caucasian-vs-AfricanAmerican |
8.592200E-01 |
| Caucasian-vs-Asian |
6.448800E-01 |
| AfricanAmerican-vs-Asian |
6.308600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.990300E-02 |
| Normal-vs-Female |
1.626370E-02 |
| Male-vs-Female |
8.813200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.660430E-02 |
| Normal-vs-Age(41-60Yrs) |
2.035900E-02 |
| Normal-vs-Age(61-80Yrs) |
1.473610E-01 |
| Normal-vs-Age(81-100Yrs) |
1.100800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.063000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.009400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.017600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.294400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.882600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.352400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.441800E-02 |
| Classical-VS-Follicular |
2.620800E-01 |
| Classical-VS-Other |
4.598200E-01 |
| Classical-VS-Normal |
6.203700E-02 |
| Tall-VS-Follicular |
3.121800E-01 |
| Tall-VS-Other |
8.090200E-01 |
| Tall-VS-Normal |
2.643200E-03 |
| Follicular-VS-Other |
8.053800E-01 |
| Follicular-VS-Normal |
2.748000E-02 |
| Other-VS-Normal |
1.511970E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.466100E-02 |
| Normal-vs-N1 |
1.761650E-03 |
| N0-vs-N1 |
3.826300E-02 |
|
|
